Solid Biosciences Inc. SLDB Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $59.9M-25.3% | $80.24M+8.4% | $74.02M-52.4% | $155.38M+30.4% | ||
| $127.95M+86.3% | $68.69M+38.4% | $49.63M-14.9% | $58.34M-34.2% | ||
| $1.22M— | $0-100% | $1.83M0.0% | $1.83M-11.4% | ||
| $16.38M+95.5% | $8.38M+37.5% | $6.09M+3.0% | $5.92M-59.8% | ||
| $205.46M+30.6% | $157.3M+21.2% | $129.73M-40.9% | $219.64M-1.3% | ||
| $4.17M-12.2% | $4.75M-28.3% | $6.62M-31.4% | $9.66M+49.4% | ||
| $21.92M-9.8% | $24.3M-8.5% | $26.54M-8.3% | $28.95M+2,435% | ||
| $223K-39.1% | $366K+75.1% | $209K+19.4% | $175K+86.2% | ||
| $27.08M-13.6% | $31.36M-10.9% | $35.21M— | —— | ||
| $232.54M+23.3% | $188.66M+14.4% | $164.94M-36.6% | $260.25M+12.0% | ||
| $3.22M-23.9% | $4.24M+109% | $2.03M-37.2% | $3.24M-27.4% | ||
| $18.95M-4.6% | $19.85M+95.4% | $10.16M+72,479% | $14K-60.0% | ||
| $2.1M+17.7% | $1.79M-3.7% | $1.86M-2.2% | $1.9M+50.2% | ||
| $33.47M+10.6% | $30.26M+108% | $14.52M-35.5% | $22.51M-4.6% | ||
| $19.06M-9.9% | $21.16M-6.8% | $22.71M-6.5% | $24.28M+8,729% | ||
| —— | $0-100% | $1.23M-27.5% | $1.7M+481% | ||
| $19.06M-9.9% | $21.16M-11.6% | $23.94M— | —— | ||
| $52.53M+2.2% | $51.42M+33.7% | $38.46M-20.8% | $48.59M+101% | ||
| —— | —— | —— | —— | ||
| $79K+97.5% | $40K+100% | $20K0.0% | $20K+186% | ||
| $1.14B+23.6% | $920.61M+17.2% | $785.2M+1.4% | $774.45M+13.1% | ||
| -$957.78M-22.3% | -$783.45M-18.9% | -$658.75M-17.1% | -$562.74M-18.0% | ||
| $52K+10.6% | $47K+213% | $15K+122% | -$68K-51.1% | ||
| $180.01M+31.2% | $137.25M+8.5% | $126.48M-40.2% | $211.67M+1.7% | ||
| $232.54M+23.3% | $188.66M+14.4% | $164.94M-36.6% | $260.25M+12.0% | ||
| $127.95M+86.3% | $68.69M+38.4% | $49.63M-14.9% | $58.34M-34.2% | ||
| $223K-39.1% | $366K+75.1% | $209K+19.4% | $175K+86.2% | ||
| $21.92M-9.8% | $24.3M-8.5% | $26.54M-8.3% | $28.95M+2,435% | ||
| $21.92M-9.8% | $24.3M-8.5% | $26.54M-8.3% | $28.95M+2,435% | ||
| $223K-39.1% | $366K+75.1% | $209K+19.4% | $175K+86.2% | ||
| $21.92M-9.8% | $24.3M-8.5% | $26.54M-8.3% | $28.95M+2,435% | ||
| $223K-39.1% | $366K+75.1% | $209K+19.4% | $175K+86.2% | ||
| $18.95M-4.6% | $19.85M+95.4% | $10.16M-39.1% | $16.69M+75.2% | ||
| $18.95M-4.6% | $19.85M+95.4% | $10.16M-39.1% | $16.69M+75.2% | ||
| $9.2M+192% | $3.15M— | $0— | —— | ||
| $9.2M+192% | $3.15M— | $0— | —— | ||
| $21.16M-12.5% | $24.18M-7.9% | $26.27M-8.0% | $28.55M+1,144% | ||
| $1.14B+23.6% | $920.61M+17.2% | $785.2M+1.4% | $774.45M+13.1% | ||
| $79K+97.5% | $40K+100% | $20K0.0% | $20K+186% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Solid Biosciences Inc.'s total assets?
- Solid Biosciences Inc. (SLDB) holds $422.9M in total assets, up 23.0% year over year.
- How much debt does Solid Biosciences Inc. have?
- Solid Biosciences Inc. carries $20.7M in total debt against $374.1M of shareholders' equity, a debt-to-equity ratio of 0.06.
- How much cash does Solid Biosciences Inc. have?
- Solid Biosciences Inc. holds $297.1M in cash and equivalents.
- Can Solid Biosciences Inc. cover its short-term obligations?
- Its current ratio is 13.10 — current assets exceed current liabilities.
- Where does Solid Biosciences Inc.'s balance sheet data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
